Key facts
- It has raised $7.8M; the latest was Early Stage VC ($7.8M) in Dec 2024.
- Notable investors include Tech Incubator Program for Startup, KB Investment, Korea Investment Partners, IBK Changgong, DAYLI Partners — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Aldaver
- ·The full record, as it builds
Funding rounds
No funding rounds for Aldaver are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aldaver
Operator of a surgical training model intended to help medical professionals improve their skills. The company specializes in creating customized artificial organ models using novel biopolymer materials that closely mimic human tissues and 3D printing technology with the customer's desired conditions, enabling medical professionals to improve to practice their skills in a safe and controlled environment.
- Sector
- Healthcare
- HQ
- Daejeon, South Korea
- Founded
- 2022
- Employees
- 39
- Website
- aldaver.co.kr/
- Ownership
- Privately Held (backing)
Aldaver doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aldaver shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aldaver in its N-PORT filings yet. We sweep new filings monthly.